| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP, Chief Scientific Officer | EVP, Global Research And CSO
1 company
Altshuler David is an EVP, Chief Scientific Officer at VERTEX PHARMACEUTICALS INC / MA. Recent SEC Form 4 filings include 0 buys and 39 sells.
Estimated insider holdings value: $10.5M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 17, 2021 | VRTX Vertex Pharmaceuticals Inc / Ma | EVP, Global Research And CSO | Sell | 79 | $216.36 | $17,092.79 | - | -11.7% | +21.0% | |
| Feb 25, 2021 | VRTX Vertex Pharmaceuticals Inc / Ma | EVP, Global Research And CSO | Sell | 3,028 | $213.39 | $646,138.52 | -2.1% | -2.9% | +8.1% | |
| Feb 18, 2021 | VRTX Vertex Pharmaceuticals Inc / Ma | EVP, Global Research And CSO | Sell | 7,825 | $211.83 | $1,657,590.08 | -4.5% | +2.0% | +9.4% | |
| Feb 11, 2021 | VRTX Vertex Pharmaceuticals Inc / Ma | EVP, Global Research And CSO | Sell | 5,283 | $210.54 | $1,112,273.86 | -4.7% | +1.0% | +11.1% | |
| Nov 16, 2020 | VRTX Vertex Pharmaceuticals Inc / Ma | EVP, Global Research And CSO | Sell | 38 | $223.47 | $8,491.96 | - | - | - | |
| Aug 6, 2020 | VRTX Vertex Pharmaceuticals Inc / Ma | EVP, Global Research And CSO | Sale+OE | 1,223 | $271.19 | $331,662.77 | -1.4% | - | - | |
| Aug 3, 2020 | VRTX Vertex Pharmaceuticals Inc / Ma | EVP, Global Research And CSO | Sale+OE | 2,330 | $278.24 | $648,290.05 | -1.9% | - | - | |
| May 15, 2020 | VRTX Vertex Pharmaceuticals Inc / Ma | EVP, Global Research And CSO | Sell | 82 | $284.37 | $23,318.29 | - | - | - | |
| May 12, 2020 | VRTX Vertex Pharmaceuticals Inc / Ma | EVP, Global Research And CSO | Sale+OE | 1,304 | $287.33 | $374,678.32 | -4.3% | - | - | |
| May 6, 2020 | VRTX Vertex Pharmaceuticals Inc / Ma | EVP, Global Research And CSO | Sale+OE | 1,222 | $272.66 | $333,195.35 | -1.0% | - | - |